Mimicking Bone Microenvironment for Directing Adipose Tissue-Derived Mesenchymal Stem Cells into Osteogenic Differentiation

Author(s):  
ZuFu Lu ◽  
Seyed-Iman Roohani-Esfahani ◽  
Hala Zreiqat

2007 ◽  
Vol 13 (10) ◽  
pp. 2495-2503 ◽  
Author(s):  
M. Knippenberg ◽  
M.N. Helder ◽  
J.M.A. de Blieck-Hogervorst ◽  
P.I.J.M. Wuisman ◽  
J. Klein-Nulend


2017 ◽  
Vol 69 (6) ◽  
pp. 1573-1580
Author(s):  
K.P. Oliveira ◽  
A.M.S. Reis ◽  
A.P. Silva ◽  
C.L.R. Silva ◽  
A.M. Goes ◽  
...  

ABSTRACT The objective was to evaluate the in vitro effect of prolactin in osteogenic potential of adipose tissue-derived mesenchymal stem cells (ADSCs) in female rats. ADSCs were cultured in osteogenic medium with and without the addition of prolactin and distributed into three groups: 1) ADSCs (control), 2) ADSCs with addition of 100ng/mL of prolactin and 3) ADSCs with addition of 300ng/mL of prolactin. At 21 days of differentiation, the tests of MTT conversion into formazan crystals, percentage of mineralized nodules and cells per field and quantification of genic transcript for alkaline phosphatase, osteopontin, osteocalcin, bone sialoprotein, BMP-2 and collagen I by real-time RT-PCR were made. The addition of prolactin reduced the conversion of MTT in group 3 and increased the percentage of cells per field in the groups 2 and 3, however without significantly increasing the percentage of mineralized nodules and the expression of alkaline phosphatase, osteopontin, osteocalcin, bone sialoprotein, BMP-2 and collagen I. In conclusion, the addition of prolactin in concentrations of 100ng/mL and 300ng/mL does not change the osteogenic differentiation to the ADSCs of female rats despite increase in the cellularity of the culture.





2019 ◽  
Vol 121 (3) ◽  
pp. 344-353 ◽  
Author(s):  
Mohamed I. Elashry ◽  
Shumet T. Gegnaw ◽  
Michele C. Klymiuk ◽  
Sabine Wenisch ◽  
Stefan Arnhold


2019 ◽  
Vol 107 (6) ◽  
pp. 1284-1293 ◽  
Author(s):  
Zohreh Karimi ◽  
Ehsan Seyedjafari ◽  
Fatemeh Sadat Mahdavi ◽  
Seyed Mahmoud Hashemi ◽  
Arash Khojasteh ◽  
...  


2011 ◽  
Vol 33 (6) ◽  
pp. 1257-1264 ◽  
Author(s):  
Abbas Shafiee ◽  
Ehsan Seyedjafari ◽  
Masoud Soleimani ◽  
Naser Ahmadbeigi ◽  
Peyman Dinarvand ◽  
...  


2018 ◽  
Vol 117 ◽  
pp. 45-53 ◽  
Author(s):  
Mohamed I. Elashry ◽  
Nadine Baulig ◽  
Manuela Heimann ◽  
Caroline Bernhardt ◽  
Sabine Wenisch ◽  
...  


2017 ◽  
Vol 64 (2) ◽  
Author(s):  
Alicja Zajdel ◽  
Magdalena Kałucka ◽  
Edyta Kokoszka-Mikołaj ◽  
Adam Wilczok

Induced osteogenesis of mesenchymal stem cells (MSCs) may provide an important tool for bone injures treatment. Human umbilical cord and adipose tissue are routinely discarded as clinical waste and may be used as uncontroversial MSCs sources. It still remains to be verified which source of MSCs is the most suitable for bone regeneration.The aim of this research was to investigate the osteogenic potential of human MSCs derived from adipose tissue (ASCs) and Wharton’s jelly of the human umbilical cord (WJ-MSCs) differentiated under the same conditions.Osteogenic differentiation of MSCs was detected and quantified by ARS staining for calcium deposition and alkaline phosphatase (ALP) activity, osteoprotegerin (OPG), and osteocalcin (OC) secretion measurements. Under osteogenic conditions the measured ALP activity and calcium deposition were significantly higher in ASCs than in WJ-MSCs, while the OPG and OC secretion were higher in WJ-MSCs vs. ASCs. Low concentrations of OPG and high levels of OC in ASCs and WJ-MSCs, prove that these cells reached an advanced stage of the osteogenic differentiation. The levels of OC secreted by ASCs were lower than by WJ-MSCs what indicates that the differentiation process of the ASCs reached the stage when the extracellular matrix is overproduced and the down-regulation of OC begins.Both cell types, ASCs and WJ-MSCs possess potential to differentiate towards the osteogenic lineage. However, the observed differences in the levels of osteogenic markers suggest that ASCs may be better candidates for cell-based osteogenesis than WJ-MSCs.



2019 ◽  
Vol 20 (24) ◽  
pp. 6242 ◽  
Author(s):  
Ilya Nifant’ev ◽  
Tatiana Bukharova ◽  
Alexander Dyakonov ◽  
Dmitry Goldshtein ◽  
Elena Galitsyna ◽  
...  

There is a current clinical need for the development of bone void fillers and bioactive bone graft substitutes. The use of mesenchymal stem cells (MSCs) that are seeded into 3D scaffolds and induce bone generation in the event of MSCs osteogenic differentiation is highly promising. Since calcium ions and phosphates promote the osteogenic differentiation of MSCs, the use of the calcium complexes of phosphate-containing polymers is highly prospective in the development of osteogenic scaffolds. Calcium poly(ethylene phosphate)s (PEP-Ca) appear to be potentially suitable candidates primarily because of PEP’s biodegradability. In a series of experiments with human adipose-tissue-derived multipotent mesenchymal stem cells (ADSCs), we demonstrated that PEP-Ca are non-toxic and give rise to osteogenesis gene marker, bone morphogenetic protein 2 (BMP-2) and mineralization of the intercellular matrix. Owing to the synthetic availability of poly(ethylene phosphoric acid) block copolymers, these results hold out the possibility for the development of promising new polymer composites for orthopaedic and maxillofacial surgery.



2014 ◽  
Vol 35 (6) ◽  
pp. 426-436 ◽  
Author(s):  
Alessia Ongaro ◽  
Agnese Pellati ◽  
Leila Bagheri ◽  
Cinzia Fortini ◽  
Stefania Setti ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document